A subscription to JoVE is required to view this content. Sign in or start your free trial.
The blood-brain barrier (BBB) is a multicellular neurovascular unit tightly regulating brain homeostasis. By combining human iPSCs and organ-on-chip technologies, we have generated a personalized BBB chip, suitable for disease modeling and CNS drug penetrability predictions. A detailed protocol is described for the generation and operation of the BBB chip.
The blood brain barrier (BBB) is formed by neurovascular units (NVUs) that shield the central nervous system (CNS) from a range of factors found in the blood that can disrupt delicate brain function. As such, the BBB is a major obstacle to the delivery of therapeutics to the CNS. Accumulating evidence suggests that the BBB plays a key role in the onset and progression of neurological diseases. Thus, there is a tremendous need for a BBB model that can predict penetration of CNS-targeted drugs as well as elucidate the BBB's role in health and disease.
We have recently combined organ-on-chip and induced pluripotent stem cell (iPSC) technologies to generate a BBB chip fully personalized to humans. This novel platform displays cellular, molecular, and physiological properties that are suitable for the prediction of drug and molecule transport across the human BBB. Furthermore, using patient-specific BBB chips, we have generated models of neurological disease and demonstrated the potential for personalized predictive medicine applications. Provided here is a detailed protocol demonstrating how to generate iPSC-derived BBB chips, beginning with differentiation of iPSC-derived brain microvascular endothelial cells (iBMECs) and resulting in mixed neural cultures containing neural progenitors, differentiated neurons, and astrocytes. Also described is a procedure for seeding cells into the organ chip and culturing of the BBB chips under controlled laminar flow. Lastly, detailed descriptions of BBB chip analyses are provided, including paracellular permeability assays for assessing drug and molecule permeability as well as immunocytochemical methods for determining the composition of cell types within the chip.
The BBB is a highly selective barrier that separates the CNS from the circulating blood. It protects critical brain functions from potentially disruptive substances, factors, and xenobiotics while also allowing the influx of nutrients and other metabolites required to maintain brain homeostasis1. The BBB is a multicellular NVU in which pericytes, astrocyte endfeet, and neuronal processes directly contact brain microvascular endothelial cells (BMECs). These interactions allow BMECs to form specialized barrier properties that are supported by tight and adherens junctions2,3. The formation....
1. Generation of iPSC-derived neural progenitor cells (iNPCs)
Figure 6A,B,C represents a BBB chip seeded with EZ-spheres on the "brain side" top channel and iBMECs on the "blood side'" bottom channel. iBMECs were seeded first and allowed to attach overnight, after which EZ-spheres were seeded. Chips were then cultured under static conditions with daily media replacement for seven days. The BBB chip was then fixed using 4% PFA at RT for 10 min and washed 3x with DPBS. Immunocytochemistry was performed on the BBB chip.......
The combination of organ-on-chip technology and iPSC-derived cells in the NVU holds promise for accurate modeling of the human BBB. Here, we provide a detailed protocol for simple and robust application of the recently published iPSC-based BBB chip16. An overview and timing of the seeding paradigm is shown in Figure 3. To obtain and maintain barrier functions that are suitable for BBB modeling, generating a homogenous iBMEC monolayer and retaining its integrity are cr.......
We would like to thank Dr. Soshana Svendsen for critical editing. This work was supported by the Israel Science Foundation grant 1621/18, the Ministry of Science and Technology (MOST), Israel 3-15647, the California Institute for Regenerative Medicine grant ID DISC1-08800, the Sherman Family Foundation, NIH-NINDS grant 1UG3NS105703, and The ALS Association grant 18-SI-389. AH was funded by Wallenberg Foundation (grant number 2015.0178).
....Name | Company | Catalog Number | Comments |
Accutase | EMD Millipore | SCR005 | Dissociation solution |
B27 | Gibco | 12587010 | |
Bfgf | Peprotech | 100-18B | |
Chip-S1 | Emulate Inc | Chip-S1 | Organ-Chip |
Collagen IV | Sigma | C5533 | |
DAPI | Invitrogen | D3571 | |
Dextran-FITC | Sigma | 46944 | |
DMEM: F12 | Thermo Fisher Scientific | 31330038 | |
Donkey serum | Sigma | D9663 | |
Emulate Reagent 1 (ER-1) | Emulate Inc | ER-1 | |
Emulate Reagent 2 (ER-2) | Emulate Inc | ER-2 | |
Fibronectin | Sigma | F1141 | |
Glial Fibrillary Acidic Protein (GFAP) | Dako | Z0334 | |
GLUT-1 | Invitrogen | MA5-11315 | |
Glutamax | Life Technologies | 35050038 | Glutamine supplement |
hBDNF | Peprotech | 450-02 | |
KOSR | Thermo Fisher Scientific | 10828028 | |
Laminin | Sigma | L2020 | |
Matrigel | Corning | 354234 | Basement membrane matrix |
mTeSR1 | StemCell Technologies, Inc. | 85851 | |
NEAA | Biological industries | 01-340-1B | |
Nestin | Millipore | MAB353 | |
NutriStem | Biological industries | 05-100-1A | Alternate media |
PECAM-1 | Thermo Fisher Scientific | 10333 | |
Platelet-poor plasma-derived bovine serum (PPP) | Biomedical Technologies | J64483AB | |
Retinoic acid (RA) | Sigma | R2625 | |
S100β | Abcam | ab6602 | |
Steriflip-GP Sterile Centrifuge Tube Top Filter Unit | Millipore | SCGP00525 | |
Triton X-100 | Sigma | X100 | |
ZO-1 Monoclonal Antibody | Invitrogen | 33-9100 | |
βIII-tubulin (Tuj1α) | Sigma | T8660 | |
β-mercaptoethanol | Life Technologies | 31350010 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved